Prudential-backed Prismic Life closes oversubscribed US$1.9 billion capital raise

Quantum BioPharma
Prudential Financial

Quantum BioPharma

QNTM

0.00

Prudential Financial

PRU

0.00
  • Prismic Life, sponsored by Prudential Financial and Warburg Pincus, closed an oversubscribed capital raise with about US$ 1.9 billion of total commitments, above its US$ 1.6 billion target.
  • The additional capital expands Prismic’s capacity to pursue a wider set of life and annuity reinsurance transactions.
  • Including this closing, Prismic has raised more than US$ 3.3 billion to support reinsurance of liabilities, including Prudential’s US and Japan blocks, alongside third-party business.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prudential Financial Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260520537530) on May 20, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.